CIAM
TARS icon

Caitong International Asset Management’s Tarsus Pharmaceuticals TARS Stock Holding History

Caitong International Asset Management’s Portfolio TARS Stock Details TARS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$103K Buy
1,644
+1,281
+353% +$81.8K 0.01% 550
2026
Q1 		$25.5K Buy
+363
New +$25.4K ﹤0.01% 954
2025
Q3 		– Sell
-139
Closed -$5.63K – 2499
2025
Q2 		$5.63K Buy
+139
New +$6.26K ﹤0.01% 968

Other funds holding TARS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Caitong International Asset Management's TARS Position: Q2 2026 in Review

Caitong International Asset Management increased its Tarsus Pharmaceuticals (TARS) stake by 353% in Q2 2026, buying an estimated $81.8K and bringing the position to 1,644 shares worth $103K. The position accounts for 0.01% of the portfolio, ranked #550.

Caitong International Asset Management first reported a position in TARS in Q2 2025 and has held it in 3 quarters since. 257 funds tracked by Wall St. Rank hold TARS as of Q2 2026.

  • Caitong International Asset Management held 1,644 shares of Tarsus Pharmaceuticals worth $103K as of Q2 2026.
  • Caitong International Asset Management bought 1,281 Tarsus Pharmaceuticals shares in Q2 2026, an estimated $81.8K.
  • Tarsus Pharmaceuticals made up 0.01% of Caitong International Asset Management's portfolio in Q2 2026, its #550 holding.
  • Caitong International Asset Management first reported a position in Tarsus Pharmaceuticals in Q2 2025 and has held it in 3 quarters since.
  • 257 funds tracked by Wall St. Rank held Tarsus Pharmaceuticals as of Q2 2026.

Based on Caitong International Asset Management's 13F filing for Q2 2026, filed 5 Aug 2026.